Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 58.95
+1.10 (1.90%)
At close: Sep 24, 2025
Amwill Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| 405.82 | 439.48 | 301.66 | 276.13 | 179.99 | Upgrade | |
Revenue Growth (YoY) | -7.66% | 45.69% | 9.25% | 53.41% | 12465.18% | Upgrade |
Cost of Revenue | 116.16 | 121.1 | 90.68 | 87.71 | 80.3 | Upgrade |
Gross Profit | 289.66 | 318.38 | 210.98 | 188.43 | 99.7 | Upgrade |
Selling, General & Admin | 102.41 | 94.22 | 104.82 | 86.93 | 70.42 | Upgrade |
Other Operating Expenses | 70.21 | 57.49 | 62.74 | 64.02 | 39.52 | Upgrade |
Operating Expenses | 177.7 | 154.1 | 170.4 | 154.22 | 110.01 | Upgrade |
Operating Income | 111.96 | 164.28 | 40.58 | 34.2 | -10.31 | Upgrade |
Interest & Investment Income | 7.07 | 3.08 | 1.16 | 0.02 | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | -0 | Upgrade |
EBT Excluding Unusual Items | 119.03 | 167.36 | 41.74 | 34.22 | -10.31 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.28 | - | -0.88 | - | Upgrade |
Pretax Income | 119.03 | 167.64 | 41.74 | 33.35 | -10.31 | Upgrade |
Income Tax Expense | 11.73 | 42.64 | 10.6 | 7.61 | -0.33 | Upgrade |
Net Income | 107.3 | 125 | 31.14 | 25.74 | -9.98 | Upgrade |
Net Income to Common | 107.3 | 125 | 31.14 | 25.74 | -9.98 | Upgrade |
Net Income Growth | -14.16% | 301.36% | 21.01% | - | - | Upgrade |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | Upgrade |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 | Upgrade |
Shares Change (YoY) | 3.71% | 0.02% | - | - | 51887.16% | Upgrade |
EPS (Basic) | 6.63 | 8.01 | 2.00 | 1.65 | -0.64 | Upgrade |
EPS (Diluted) | 6.63 | 8.01 | 2.00 | 1.65 | -0.64 | Upgrade |
EPS Growth | -17.23% | 301.27% | 21.02% | - | - | Upgrade |
Free Cash Flow | 48.48 | -39.47 | 44.77 | 29.07 | -7.32 | Upgrade |
Free Cash Flow Per Share | 3.00 | -2.53 | 2.87 | 1.86 | -0.47 | Upgrade |
Gross Margin | 71.38% | 72.45% | 69.94% | 68.24% | 55.39% | Upgrade |
Operating Margin | 27.59% | 37.38% | 13.45% | 12.39% | -5.73% | Upgrade |
Profit Margin | 26.44% | 28.44% | 10.32% | 9.32% | -5.54% | Upgrade |
Free Cash Flow Margin | 11.95% | -8.98% | 14.84% | 10.53% | -4.07% | Upgrade |
EBITDA | 116.32 | 166.62 | 42.89 | 37.46 | -10.25 | Upgrade |
EBITDA Margin | 28.66% | 37.91% | 14.22% | 13.56% | -5.69% | Upgrade |
D&A For EBITDA | 4.36 | 2.33 | 2.31 | 3.25 | 0.07 | Upgrade |
EBIT | 111.96 | 164.28 | 40.58 | 34.2 | -10.31 | Upgrade |
EBIT Margin | 27.59% | 37.38% | 13.45% | 12.39% | -5.73% | Upgrade |
Effective Tax Rate | 9.86% | 25.44% | 25.39% | 22.82% | - | Upgrade |
Revenue as Reported | 412.89 | 442.84 | 302.83 | 276.15 | 179.99 | Upgrade |
Advertising Expenses | 27.26 | 37.68 | 29.33 | 22.34 | 31.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.